PICAROS - Acalabrutinib RWE on 1L CLL in Spain

Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL

NCT04883749 ·Status: COMPLETED ·Phase: PHASE2

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

NCT02477696 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

NCT02475681 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

NCT06651970 ·Status: RECRUITING ·Phase: PHASE4

A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.

NCT06319456 ·Status: RECRUITING ·Phase: PHASE3

Early Intervention With Acalabrutinib in Patients With High Risk CLL

NCT04660045 ·Status: WITHDRAWN ·Phase: PHASE2

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

NCT02337829 ·Status: COMPLETED ·Phase: PHASE2

Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT06757647 ·Status: RECRUITING ·Phase: PHASE2

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

NCT04716075 ·Status: COMPLETED ·Phase: PHASE2

Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

NCT03788291 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain

NCT06125795 ·Status: ACTIVE_NOT_RECRUITING

National Acalabrutinib Observational Study

NCT05437250 ·Status: ACTIVE_NOT_RECRUITING

A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL

NCT05950997 ·Status: RECRUITING ·Phase: NA

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT03516617 ·Status: RECRUITING ·Phase: PHASE2

Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL

NCT04685915 ·Status: WITHDRAWN ·Phase: PHASE2

STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT04963946 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

ALICIA (Acalabrutinib in CLL Therapy)

NCT04746950 ·Status: ACTIVE_NOT_RECRUITING

AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

NCT06548152 ·Status: RECRUITING

A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma

NCT03505554 ·Status: UNKNOWN ·Phase: PHASE2

A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies

NCT03198650 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

NCT03331198 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

NCT01862445 ·Status: UNKNOWN

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

NCT04578613 ·Status: UNKNOWN ·Phase: PHASE3

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01886859 ·Status: COMPLETED ·Phase: PHASE1

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)

NCT01010061 ·Status: COMPLETED ·Phase: PHASE3